← all drugs
Pramlintide Acetate Injection
being discontinued · Endocrinology/Metabolism · Snapshot: 2026-08-25
- Manufacturers listed
- AstraZeneca AB
- Machine-readable
- JSON for this drug
Presentations (2)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| SymlinPen® 120 , Injection, 1000 ug/1 mL (NDC 0310-6627-02) | AstraZeneca AB | unknown | 10/27/2025 |
| SymlinPen® 60 , Injection, 1000 ug/1 mL (NDC 0310-6615-02) | AstraZeneca AB | unknown | 10/27/2025 |
History
Daily change tracking began 2026-08-25 (index founding). Status flips and availability changes will accumulate here.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.